🇺🇸 Exentide in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 12

Most-reported reactions

1. Nausea — 3 reports (25%)
2. Alopecia — 1 report (8.33%)
3. Blood Glucose Decreased — 1 report (8.33%)
4. Blood Glucose Increased — 1 report (8.33%)
5. Chest Pain — 1 report (8.33%)
6. Chronic Obstructive Pulmonary Disease — 1 report (8.33%)
7. Diabetic Neuropathy — 1 report (8.33%)
8. Diabetic Retinopathy — 1 report (8.33%)
9. Dizziness — 1 report (8.33%)
10. Dyspepsia — 1 report (8.33%)

Source database →

Frequently asked questions

Is Exentide approved in United States?

Exentide does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Exentide in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.